{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:38:53Z","timestamp":1778690333286,"version":"3.51.4"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060261"],"award-info":[{"award-number":["No. 82060261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>This study was performed to evaluate the effects of prenatal baclofen (a GABAB receptor agonist) treatment on the inheritance of autism-like behaviors in valproic acid (VPA)-exposed mice. VPA model mice (first generation, F1) that were prenatally exposed to VPA exhibited robust core autism-like behaviors, and we found that oral administration of baclofen to F1 mice corrected their autism-like behavioral phenotypes at an early age. Based on a previous epigenetics study, we mated the F1 male offspring with litter females to produce the second generation (F2). The F2 male mice showed obvious inheritance of autism-like phenotypes from F1 mice, implying the heritability of autism symptoms in patients with prenatal VPA exposure. Furthermore, we found prenatal baclofen administration was associated with beneficial effects on the autism-like phenotype in F2 male mice. This may have involved corrections in the density of total\/mature dendritic spines in the hippocampus (HC) and medial prefrontal cortex (mPFC), normalizing synaptic plasticity. In this research, GABAB receptor agonist administration corrected the core autism-like behaviors of F1 mice and protected against the inheritance of neurodevelopmental disorders in the offspring of F1 mice, suggesting the potential of early intervention with GABAB receptor agonists in the treatment of neurodevelopmental disorders.<\/jats:p>","DOI":"10.3389\/fpsyt.2022.835993","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:40:52Z","timestamp":1650001252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Prenatal GABAB Receptor Agonist Administration Corrects the Inheritance of Autism-Like Core Behaviors in Offspring of Mice Prenatally Exposed to Valproic Acid"],"prefix":"10.3389","volume":"13","author":[{"given":"Shucai","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maotao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baorui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caibin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/09687599.2015.1062233","article-title":"Diagnostic and statistical manual of mental disorders: DSM-5\u2122 (5th ed.)","volume":"25","year":"2013","journal-title":"Codas."},{"key":"B2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1017\/S0954579420002047","article-title":"Seeing the forest and the trees: disentangling autism phenotypes in the age of DSM-5","volume":"33","author":"Volkmar","year":"2021","journal-title":"Dev Psychopathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neubiorev.2020.12.009","article-title":"Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story","volume":"121","author":"Carbone","year":"2021","journal-title":"Neurosci Biobehav Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6513a1","volume":"65","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6802a1","article-title":"Prevalence and characteristics of autism spectrum disorder among children aged 4 years - early autism and developmental disabilities monitoring network, seven sites, United States, 2010, 2012, and 2014","volume":"68","author":"Christensen Deborah","year":"2019","journal-title":"MMWR Surveill Summ."},{"key":"B6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/FBP.0000000000000163","article-title":"Modeling autism-relevant behavioral phenotypes in rats and mice: do 'autistic' rodents exist","volume":"26","author":"Servadio","year":"2015","journal-title":"Behav Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1542\/peds.2011-0427","article-title":"A systematic review of medical treatments for children with autism spectrum disorders","volume":"127","author":"McPheeters","year":"2011","journal-title":"Pediatrics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fnins.2018.00304","article-title":"Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder","volume":"12","author":"Eissa","year":"2018","journal-title":"Front Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism\u2013a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol Teratol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"107477","DOI":"10.1016\/j.neuropharm.2018.12.024","article-title":"Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder","volume":"159","author":"Tartaglione","year":"2019","journal-title":"Neuropharmacology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism","volume":"2","author":"Rinaldi","year":"2008","journal-title":"Front Neural Circuits."},{"key":"B14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/cercor\/bhm117","article-title":"Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid","volume":"18","author":"Rinaldi","year":"2008","journal-title":"Cereb Cortex."},{"key":"B15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.31887\/DCNS.2012.14.3\/jcrawley","article-title":"Translational animal models of autism and neurodevelopmental disorders","volume":"14","author":"Crawley","year":"2012","journal-title":"Dialogues Clin Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1017\/S1461145712001216","article-title":"Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism","volume":"16","author":"Banerjee","year":"2013","journal-title":"Int J Neuropsychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2013.03.030","article-title":"Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder","volume":"241","author":"Bringas","year":"2013","journal-title":"Neuroscience."},{"key":"B18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbr.2016.09.003","article-title":"Downregulation of glutamatergic and GABAergic proteins in valproric acid associated social impairment during adolescence in mice","volume":"316","author":"Chau","year":"2017","journal-title":"Behav Brain Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fnbeh.2018.00182","article-title":"A developmental study of abnormal behaviors and altered GABAergic signaling in the VPA-treated rat model of autism","volume":"12","author":"Hou","year":"2018","journal-title":"Front Behav Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fncel.2019.00479","article-title":"Reward-related behavioral, neurochemical and electrophysiological changes in a rat model of autism based on prenatal exposure to valproic acid","volume":"13","author":"Schiavi","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"152500","DOI":"10.1016\/j.tox.2020.152500","article-title":"Altered expression of glutamatergic and GABAergic genes in the valproic acid-induced rat model of autism: a screening test","volume":"440","author":"Lenart","year":"2020","journal-title":"Toxicology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuroscience.2020.02.029","article-title":"Long-lasting behavioral and neuroanatomical effects of postnatal valproic acid treatment","volume":"434","author":"Norton","year":"2020","journal-title":"Neuroscience."},{"key":"B23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.biopsych.2016.05.011","article-title":"Excitation\/inhibition imbalance in animal models of autism spectrum disorders","volume":"81","author":"Lee","year":"2017","journal-title":"Biol Psychiatry."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1038\/tp.2012.69","article-title":"GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction","volume":"2","author":"Gandal","year":"2012","journal-title":"Transl Psychiatry."},{"key":"B25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature11356","article-title":"Autistic-like behaviour in Scn1a+\/- mice and rescue by enhanced GABA-mediated neurotransmission","volume":"489","author":"Han","year":"2012","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"152ra128","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen","volume":"4","author":"Henderson","year":"2012","journal-title":"Sci Transl Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/ijnp\/pyv034","article-title":"R-baclofen reverses a social behavior deficit and elevated protein synthesis in a mouse model of fragile X syndrome","volume":"18","author":"Mei","year":"2015","journal-title":"Int J Neuropsychoph."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/npp.2015.66","article-title":"GABAB receptor agonist R-baclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism","volume":"40","author":"Silverman","year":"2015","journal-title":"Neuropsychopharmacology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"ENEURO","DOI":"10.1523\/ENEURO.0380-16.2017","article-title":"GABA-B agonist baclofen normalizes auditory-evoked neural oscillations and behavioral deficits in the Fmr1 knockout mouse model of fragile X syndrome","volume":"4","author":"Sinclair","year":"2017","journal-title":"eNeuro."},{"key":"B30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/npp.2017.236","article-title":"R-baclofen reverses cognitive deficits and improves social interactions in two lines of 16p11.2 deletion mice","volume":"43","author":"Stoppel Laura","year":"2018","journal-title":"Neuropsychopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"152ra127","DOI":"10.1126\/scitranslmed.3004214","article-title":"Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial","volume":"4","author":"Berry-Kravis","year":"2012","journal-title":"Sci Transl Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10803-013-1963-z","article-title":"STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study","volume":"44","author":"Erickson","year":"2014","journal-title":"J Autism Dev Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/DHPS.S39595","article-title":"Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder","volume":"6","author":"Frye","year":"2014","journal-title":"Drug Healthc Patient Saf."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/npp.2016.237","article-title":"Arbaclofen in children and adolescents with autism spectrum disorder: a randomized, controlled, phase 2 trial","volume":"42","author":"Veenstra-VanderWeele","year":"2017","journal-title":"Neuropsychopharmacology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00787-019-01333-5","article-title":"Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Mahdavinasab","year":"2019","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s11689-016-9181-6","article-title":"Arbaclofen in fragile X syndrome: results of phase 3 trials","volume":"9","author":"Berry-Kravis","year":"2017","journal-title":"J Neurodev Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S0033291700028099","article-title":"Autism as a strongly genetic disorder: evidence from a British twin study","volume":"25","author":"Bailey","year":"1995","journal-title":"Psychol Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1001\/jama.2014.4144","article-title":"The familial risk of autism","volume":"311","author":"Sandin","year":"2014","journal-title":"JAMA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.3390\/ijms21134726","article-title":"Clinical assessment, genetics, and treatment approaches in autism spectrum disorder (ASD)","volume":"21","author":"Genovese","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/aur.2417","article-title":"The familial risk of autism spectrum disorder with and without intellectual disability","volume":"13","author":"Xie","year":"2020","journal-title":"Autism Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jaac.2010.05.005","article-title":"Autism spectrum disorders and epigenetics","volume":"49","author":"Grafodatskaya","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41398-017-0062-x","article-title":"Epigenetics and cerebral organoids: promising directions in autism spectrum disorders","volume":"8","author":"Forsberg","year":"2018","journal-title":"Transl Psychiatry."},{"key":"B43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-030-30402-7_5","article-title":"Maternal prenatal exposures in pregnancy and autism spectrum disorder: an insight into the epigenetics of drugs and diet as key environmental influences","volume":"24","author":"Bastaki","year":"2020","journal-title":"Adv Neurobiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrino."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.reprotox.2007.09.001","article-title":"What is an epigenetic transgenerational phenotype? F3 or F2","volume":"25","author":"Skinner","year":"2008","journal-title":"Reprod Toxicol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"36250","DOI":"10.1038\/srep36250","article-title":"The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy","volume":"6","author":"Choi","year":"2016","journal-title":"Sci Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/jdn.10046","article-title":"Prenatal pregabalin is associated with sex-dependent alterations in some behavioral parameters in valproic acid-induced autism in rat offspring","volume":"80","author":"Shamsi Meymandi","year":"2020","journal-title":"Int J Dev Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pnpbp.2019.01.005","article-title":"Dendritic spines: revisiting the physiological role","volume":"92","author":"Chidambaram","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B49","doi-asserted-by":"publisher","first-page":"718","DOI":"10.12122\/j.issn.1673-4254.2019.06.14","article-title":"Improvement of a mouse model of valproic acid-induced autism","volume":"39","author":"Zheng","year":"2019","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao."},{"key":"B50","doi-asserted-by":"publisher","first-page":"104441","DOI":"10.1016\/j.psyneuen.2019.104441","article-title":"Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: relevance for susceptibility and resilience in autism","volume":"110","author":"Kazlauskas","year":"2019","journal-title":"Psychoneuroendocrinology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s11689-020-09353-y","article-title":"Controlling litter effects to enhance rigor and reproducibility with rodent models of neurodevelopmental disorders","volume":"13","author":"Jim\u00e9nez","year":"2021","journal-title":"J Neurodev Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1124\/jpet.111.183327","article-title":"Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome","volume":"338","author":"Pacey Laura K","year":"2011","journal-title":"J Pharmacol Exp Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e00991","DOI":"10.1002\/brb3.991","article-title":"Paradoxical effect of baclofen on social behavior in the fragile X syndrome mouse model","volume":"8","author":"Zeidler","year":"2018","journal-title":"Brain Behav."},{"key":"B54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn Process."},{"key":"B55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13229-017-0121-4","article-title":"Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses","volume":"8","author":"Modabbernia","year":"2017","journal-title":"Mol Autism."},{"key":"B56","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0272-0590(88)90112-1","article-title":"Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats","volume":"11","author":"Binkerd","year":"1988","journal-title":"Fundam Appl Toxicol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/mrdd.20039","article-title":"Designing mouse behavioral tasks relevant to autistic-like behaviors","volume":"10","author":"Crawley","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","article-title":"Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice","volume":"3","author":"Moy","year":"2004","journal-title":"Genes Brain Behav."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/0471142301.ns0826s56","article-title":"Automated three-chambered social approach task for mice","author":"Yang","year":"2011","journal-title":"Curr Protoc Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1038\/s41596-020-0382-9","article-title":"A standardized social preference protocol for measuring social deficits in mouse models of autism","volume":"15","author":"Rein","year":"2020","journal-title":"Nat Protoc."},{"key":"B61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","article-title":"Are the dorsal and ventral hippocampus functionally distinct structures","volume":"65","author":"Fanselow","year":"2010","journal-title":"Neuron."},{"key":"B62","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol Lett."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e26077","DOI":"10.1371\/journal.pone.0026077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"PLoS ONE."},{"key":"B64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbr.2013.09.049","article-title":"Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice","volume":"257","author":"Moldrich","year":"2013","journal-title":"Behav Brain Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0091-3057(81)90219-7","article-title":"Conditioned defensive burying: a new paradigm for the study of anxiolytic agents","volume":"15","author":"Dallas","year":"1981","journal-title":"Elsevier."},{"key":"B66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","article-title":"Evaluation of marble-burying behavior as a model of anxiety","volume":"38","author":"Kung'u","year":"1991","journal-title":"Pharmacol Biochem Behav."},{"key":"B67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.euroneuro.2020.04.007","article-title":"Similarities and dissimilarities in the effects of benzodiazepines and specific serotonin reuptake inhibitors (SSRIs) in the defensive marble burying test: a systematic review and meta-analysis","volume":"36","author":"Langer","year":"2020","journal-title":"Eur Neuropsychopharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0006-2952(92)90324-c","article-title":"Pharmacology of valproate","volume":"37","author":"Owens","year":"2003","journal-title":"Psychopharmacol Bull."},{"key":"B69","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00213-006-0317-3","article-title":"Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex","volume":"185","author":"Gobbi","year":"2006","journal-title":"Psychopharmacology."},{"key":"B70","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.tem.2009.12.007","article-title":"Epigenetic transgenerational actions of environmental factors in disease etiology","volume":"21","author":"Skinner","year":"2010","journal-title":"Trends Endocrinol Metab."},{"key":"B72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fgene.2011.00028","article-title":"Epigenetic memory in mammals","volume":"2","author":"Migicovsky","year":"2011","journal-title":"Front Genet."},{"key":"B73","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.pbiomolbio.2013.01.001","article-title":"Transgenerational epigenetic effects on animal behaviour","volume":"113","author":"Jensen","year":"2013","journal-title":"Prog Biophys Mol Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/cells8121559","article-title":"Transgenerational inheritance of environmentally induced epigenetic alterations during mammalian development","volume":"8","author":"Legoff","year":"2019","journal-title":"Cells."},{"key":"B75","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/aur.1596","article-title":"Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism","volume":"9","author":"Hara","year":"2016","journal-title":"Autism Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s00213-017-4703-9","article-title":"Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice","volume":"234","author":"Hara","year":"2017","journal-title":"Psychopharmacology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbr.2017.06.035","article-title":"Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice","volume":"333","author":"Yamaguchi","year":"2017","journal-title":"Behav Brain Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neubiorev.2021.01.024","article-title":"The postnatal GABA shift: a developmental perspective","volume":"124","author":"Peerboom","year":"2021","journal-title":"Neurosci Biobehav Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fncel.2010.00011","article-title":"GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: general rules and differences in diverse systems","volume":"4","author":"Sernagor","year":"2010","journal-title":"Front Cell Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/ncomms2820","article-title":"Non-hyperpolarizing GABAB receptor activation regulates neuronal migration and neurite growth and specification by cAMP\/LKB1","volume":"4","author":"Bony","year":"2013","journal-title":"Nat Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fncel.2013.00206","article-title":"Emerging neurotrophic role of GABAB receptors in neuronal circuit development","volume":"7","author":"Gaiarsa","year":"2013","journal-title":"Front Cell Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbr.2007.09.009","article-title":"Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder","volume":"187","author":"DeLorey","year":"2008","journal-title":"Behav Brain Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","article-title":"Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits","volume":"147","author":"Pe\u00f1agarikano","year":"2011","journal-title":"Cell."},{"key":"B84","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/gbb.12115","article-title":"Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice","volume":"13","author":"Brielmaier","year":"2014","journal-title":"Genes Brain Behav."},{"key":"B85","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature13248","article-title":"Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission","volume":"511","author":"Karayannis","year":"2014","journal-title":"Nature."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2016.01.007","article-title":"Role of GABA(B) receptors in learning and memory and neurological disorders","volume":"63","author":"Heaney","year":"2016","journal-title":"Neurosci Biobehav Rev."},{"key":"B87","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.835993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:40:57Z","timestamp":1650001257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.835993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":87,"alternative-id":["10.3389\/fpsyt.2022.835993"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.835993","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"article-number":"835993"}}